Please ensure Javascript is enabled for purposes of website accessibility
Novartis Ag Stock Quote

Novartis Ag (NYSE: NVS)

Price as of June 2, 2023, 11:24 a.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Novartis Ag Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NVS +8.33% +28.45% +5.13% +1,021%
S&P +2.92% +54.35% +9.06% +996%

Novartis Ag Company Info

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

News & Analysis

The Fool has written over 600 articles on Novartis Ag.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.